Blackstone Inc. (BX) fell 2.1% to about $117.63 on November 3, 2026, giving back part of a one-month rally of 5.2% that stalled under resistance near $120. The stock sits below its 50-day, 200-day and 40-week averages, so the weekly trend is still down. The balance of evidence leans negative with high conviction. Third-quarter earnings were solid, and nothing in the filings explains today's drop.
Why it matters
The most recent real news was the third-quarter report on October 22, 2026: GAAP net income of $1.3 billion for the quarter and $4.9 billion year to date, with $662 million of the quarter attributable to Blackstone shareholders and revenues of $3.06 billion, per SEC EDGAR. That is a profitable quarter, not a broken one. The $1.1 billion senior notes offering, priced on October 27 and completed on November 2, was ordinary financing: $600 million at 5.650% due 2031 and $500 million at 5.900% due 2033, as SEC EDGAR shows. An October 16 filing on officers and directors carried no details that could move a stock.
What the market did with this is telling. The shares climbed over the past month, peaked at a close of $120.60 on October 29, and are now 2.5% below that. Today's 2.09% decline has no news behind it. Volume is running about 62% below its 20-day average with the session still open, so this looks like a quiet slip away from resistance, not a rush to the exit. The rally that preceded it was not carried by a new fact either, which is why it has had trouble getting past the sellers who showed up at $120.11.
Over five days the stock gained 0.76%, while the S&P 500 (SPY) fell 2.06% and the financial sector (XLF) rose 2.34%. Against the market BX held up well. Against its own sector it trailed by 1.6 points, so the stock did not take part fully in the sector's strength. The longer view is weaker. Over 50 days BX lags the S&P 500 by 1.6 points and XLF by 5.3 points, and over 200 days it lags the S&P 500 by 8.2 points. Year to date the stock is down 23.7% while SPY is up 10.5%.
The material supplied contains no sourced debate on BX, so the argument is visible mainly in the numbers. Of 22 analysts, the consensus is buy, with a mean price target of $138.86, which is 15.3% above the current price. The range runs from $118 to $169, and even the lowest target sits barely above the shares. The stock is also 28% below its 52-week high of $163.50. One reading is that the shares are cheap against what analysts expect. The other is that the market has marked those targets as stale, and the price action since the high favors that second reading.
What the evidence says
On the long term, the thesis is weakened and not yet repaired. Price is below its 40-week average, the 50-day average at $121.66 sits under the 200-day at $123.71, and the stock is 15% above its 52-week low of $102.12. This is a bounce inside a downtrend, not a new uptrend. Earnings are not the problem, since the quarter was profitable. The problem is that buyers have not been willing to pay up for them.
For the next 2 to 6 weeks the balance of evidence leans negative, and conviction is high, at 3 of 4 checks. The daily trend runs with the weekly downtrend. The stock is also lagging both the S&P 500 and XLF over 50 days. One of the four checks did not line up, which is why conviction is not at the maximum.
The strongest case against this reading is momentum. The stock is up 5.2% in a month, its 14-day RSI is near 67, it beat the market over five days, and the consensus is buy with a mean target 15.3% above the price. If buyers were returning, this is how it would look. It does not tip the balance because the rally has not cleared a single meaningful ceiling: the $120.11 swing zone, the 50-day and the 200-day all sit overhead. The gain is also a recovery measured against a year-to-date loss of 23.7%.
Levels that matter
The structure stays bearish while the stock trades below $120.11, the swing zone where sellers have appeared on rallies. The weekly trend would end only above $121.66, the 50-day average. Between them lie the 200-day at $123.71 and the round $125 level, so there is a thick band of supply overhead.
On the downside, the breakout level is a daily close below $112.38. From there the first target is $105.31, which gives 0.8 to 1 against a stop at $121.15 (the $120.11 zone plus a quarter of the 14-day ATR of $4.16). The second target is the 52-week low at $102.12, which gives 1.2 to 1. The math does not reach the 3 to 1 that makes a breakout worth the risk. Only a much tighter stop or a target well below $102.12 would change that, and the round $100 level just beneath the low is too close to do it.
What would change the picture
A weekly close above $121.66, the 50-day average, would be the first sign that buyers have taken control from the sellers at $120.11. The non-price fact that could produce it is an earnings report that lifts analyst estimates and brings the low price target of $118 up toward the $138.86 mean. A price move alone through that level, without better numbers behind it, would carry less weight.
What to watch
- Earnings on January 28, 2027: the number that matters is GAAP net income attributable to Blackstone, which was $662 million in the third quarter and $2.5 billion year to date.
- The financial sector: XLF is up 6.9% over a month and BX has trailed it by 5.3 points over 50 days. A sector pullback would reach the stock before any company news does.
- Valuation against consensus: the shares trade 15.3% below the $138.86 mean target and just under the lowest target of $118. The gap closes only if the price rises or the targets fall.